U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 18 - 24, 2018
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 18 - 24, 2018

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date : 02/23/2018 - 02/23/2018
Location : Baltimore, MD
Subject : Society for Research on Nicotine &Tobacco Annual Meeting: An Update on FDA's Comprehensive Plan on Tobacco and Nicotine Regulation
FDA Participant/Group : MITCHELL ZELLER; JANET WOODCOCK; NICOLETTE BOREK; BLAIR NESMITH;
Non FDA Participant/Group : Government staff, academia, industry, media and other registered participants

Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner

No Significant Event

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

Event Date : 02/20/2018
Location : Silver Spring, MD
Subject : Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality(SENASICA): Produce
FDA Participant/Group : ERIC BROWN; KENNETH NIEVES; CAMILLE BREWER; DONALD PRATER; MARY LOU VALDEZ; SUSAN MAYNE; KATHERINE SERRANO;
Non FDA Participant/Group : Brenda Esthela Martinez Vergara (Embassy of Mexico); Enrique Sanchez Cruz, Ulises Manuel Alvares Bolanos (Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality);

Event Date : 02/22/2018
Location : College Park, MD
Subject : Food Safety
FDA Participant/Group : DOUGLAS STEARN; MARIA KNIRK; MICKEY PARISH; JOANN GIVENS; WILLIAM CORRELL; KARI IRVIN; CATHERINE MCDERMOTT; VIRGINIA SCOTT; SUSAN MAYNE; LARRY MORRIS;
Non FDA Participant/Group : Mike Liewen (PepsiCo); Rob Mommsen, Shali Shalit-Shoval (Sabra Dipping Company, LLC); Don Zink (IEH Laboratories & Consulting Group ); Randy Russell, Tyson Redpath (The Russell Group);

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name : RADM Denise Hinton , Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date : 02/22/2018 - 02/22/2018
Location : Washington, DC
Subject : Human Genome Editing Webinar
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 02/21/2018 - 02/21/2018
Location : Washington, DC
Subject : Medical Device Innovation Consortium: Board of Directors Meeting
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name : Rebecca K. Wood, J.D., Chief Counsel

Event Date : 02/23/2018 - 02/23/2018
Location : Silver Spring, Maryland
Subject : Biologics Price Competition Innovation Act (BPCIA): Transition Provision
FDA Participant/Group : JANICE WEINER; DEBORAH CHO; GRAIL SIPES; MUSTAFA UNLU; LEAH CHRISTL; JOSEPH FRANKLIN; KIM DETTELBACH; ANUJ SHAH; NANCY HAYES; ELIZABETH DICKINSON;
Non FDA Participant/Group : Brian Stone, Carmen Shepard, Rajiv Malik, Tony Mauro (Mylan); Sheldon Bradshaw (King & Spalding LLP);

Back to Top